The African Development Bank has approved a $15 million loan to Biovac for a new vaccine manufacturing facility in Cape Town, ...

The Bundibugyo strain of the Ebola virus has been devastating communities in the Democratic Republic of the Congo with no ...

New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could ...

The African Development Bank Group ( ) has finalised a loan of up to $15 million to the Biologicals and Vaccines Institute of South Africa Ltd (Biovac) ( ...

Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...

With the COVID-19 pandemic exposing the critical need for domestic vaccine production, Korea signaled Friday that it intends ...

India has approved QDENGA, its first dengue vaccine. A pulmonary specialist explains who should get vaccinated, who should ...

The Indian Council of Medical Research (ICMR) has licensed three indigenous biomedical technologies to leading domestic ...

ICMR licensed three indigenous biomedical technologies to Emcure and Biological E, advancing an HPV precancer therapy and vaccines for typhoid, paratyphoid and Shigella toward affordable commercial ...

Vaxcyte's VAX-31 is in a Phase 3 pivotal OPUS-1 noninferiority trial and is expecting topline data in 4Q 2026. Learn more ...

India has approved its first dengue vaccine, QDENGA, for people aged 4 to 60 years. Know who can receive it, how the two-dose ...